Seeking Alpha

Seeking Alpha Portfolio App for iPad

Saul Kerpelman

Saul Kerpelman picture

Profile

Send Message

View as an RSS Feed

View Saul Kerpelman's Articles BY TICKER:

ASCO Data Suggest Dendreon's Provenge Should Go First
on Wed, Jun 6, 2012 • DNDN, JNJ • 63 Comments
Dendreon: Following Up On Market Mania
on Tue, Jan 17, 2012 • DNDN • 23 Comments
Dendreon: Market Mania In Action
on Mon, Nov 7, 2011 • DNDN • 34 Comments
Dendreon: Righting The Ship
on Fri, Sep 9, 2011 • DNDN • 15 Comments
Dendreon: The Challenge Of Misinformation
on Mon, Aug 29, 2011 • DNDN • 139 Comments
Dendreon: Profits Ahead as Provenge Gets Reimbursement Approval From Medicare
on Tue, Aug 16, 2011 • DNDN • 36 Comments
Dendreon Is Way Undervalued
on Thu, Apr 21, 2011 • DNDN • 29 Comments
Why Provenge Could Be a $10 Billion Drug for Dendreon
on Mon, Apr 11, 2011 • DNDN • 18 Comments
Dendreon Learns From ICOS' Mistake
on Tue, Apr 5, 2011 • DNDN • 22 Comments
No 'Shareholder Uprising' at Dendreon
on Mon, Apr 4, 2011 • DNDN • 36 Comments
Why Dendreon Will Power Ahead Now
on Thu, Mar 31, 2011 • DNDN • 10 Comments
Good News for Dendreon's Provenge
on Fri, Feb 18, 2011 • DNDN • 45 Comments